Lysosome impairment as a trigger for inflammation in obesity: The proof is in the fat.
Obesity is a global epidemic contributing to the rising prevalence of multiple disorders including metabolic syndrome, diabetes, fatty liver disease, cardiovascular and cerebrovascular disease, Alzheimer's disease and certain cancers. A renewed sense of urgency is required as obesity remains an...
Main Authors: | David R. Rawnsley, Abhinav Diwan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | EBioMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396420301997 |
Similar Items
-
Impact of Obesity and Lysosomal Dysfunction on Chemoresistance in Ovarian Cancer
by: Boyun Kim, et al.
Published: (2024-03-01) -
Impaired lysosomal acidification triggers iron deficiency and inflammation in vivo
by: King Faisal Yambire, et al.
Published: (2019-12-01) -
Alterations in Lysosome Homeostasis in Lipid-Related Disorders: Impact on Metabolic Tissues and Immune Cells
by: Fernanda Cabrera-Reyes, et al.
Published: (2021-12-01) -
Obese visceral fat tissue inflammation: from protective to detrimental?
by: Hubert Kolb
Published: (2022-12-01) -
SMS121, a new inhibitor of CD36, impairs fatty acid uptake and viability of acute myeloid leukemia
by: Hannah Åbacka, et al.
Published: (2024-04-01)